Cogent Biosciences, Inc

(NASDAQ:UMRX)

Latest On Cogent Biosciences, Inc (UMRX):

Date/Time Type Description Signal Details
2020-11-26 21:53 ESTFinancialsCompany financials have been released.Neutral
2020-11-12 13:15 ESTFinancialsCompany financials have been released.Neutral
2020-11-11 13:18 ESTFinancialsCompany financials have been released.Neutral
2020-11-08 01:11 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 17:26 ESTFinancialsCompany financials have been released.Neutral
2020-10-13 21:28 ESTNewsUnraveling The Investment Case For Unum TherapeuticsN/A
2020-10-05 18:51 ESTNewsUnum Therapeutics now named as Cogent BiosciencesN/A
2020-10-05 06:24 ESTAnalyst RatingThe Analyst Target Price has decreased from $6 to $5.Neutral
2020-09-26 14:24 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 06:32 ESTFinancialsCompany financials have been released.Neutral
2020-08-31 16:50 ESTNewsUnum Therapeutics' BOXR CAR-T platform and products rights acquired by SOTION/A
2020-08-25 05:56 ESTAnalyst RatingThe Analyst Target Price has increased from $4 to $6.Buy
2020-08-20 01:25 ESTNewsVenrock Healthcare Capital Partners acquires 0.451M shares of Unum TherapeuticsN/A
2020-08-18 18:59 ESTInsider TradeVenrock Healthcare Capital Partners III, L.P. has acquired 101,000 shares indirectly via funds.Buy
2020-08-18 18:59 ESTInsider TradeVenrock Healthcare Capital Partners III, L.P. has acquired 250,000 shares indirectly via funds.Buy
2020-08-18 18:59 ESTInsider TradeVenrock Healthcare Capital Partners III, L.P. has acquired 100,000 shares indirectly via funds.Buy
2020-08-15 05:50 ESTFinancialsCompany financials have been released.Neutral
2020-08-14 10:26 ESTFinancialsCompany financials have been released.Neutral
2020-08-14 05:54 ESTFinancialsCompany financials have been released.Neutral
2020-08-12 01:22 ESTNewsUnum Therapeutics reports Q2 resultsN/A
2020-08-06 09:48 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 18:12 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 06:08 ESTFinancialsCompany financials have been released.Neutral
2020-07-29 22:16 ESTFinancialsCompany financials have been released.Neutral
2020-07-27 14:04 ESTFinancialsCompany financials have been released.Neutral
2020-07-23 18:46 ESTFinancialsCompany financials have been released.Neutral
2020-07-15 20:07 ESTInsider TradeJohn L. Green has directly acquired 109,459 shares and currently holds 109,459 shares.Buy
2020-07-11 00:26 ESTNewsUnum Therapeutics rallies on disclosure of Fairmont stakeN/A
2020-07-09 10:16 ESTFinancialsCompany financials have been released.Neutral
2020-07-08 01:53 ESTAnalyst RatingThe Analyst Target Price has increased from $1 to $4.Buy
2020-07-06 18:08 ESTNewsUnum Therapeutics completes Kiq buy, inks $104M capital raiseN/A
2020-07-01 18:03 ESTFinancialsCompany financials have been released.Neutral
2020-06-19 13:56 ESTFinancialsCompany financials have been released.Neutral
2020-06-14 05:59 ESTFinancialsCompany financials have been released.Neutral
2020-06-12 06:56 ESTFinancialsCompany financials have been released.Neutral
2020-06-02 13:45 ESTEarnings EstimateAn EPS average of -$0.11 is estimated for the quarter ending on September 30, 2020.Buy
2020-06-02 13:45 ESTAnalyst RatingThe Analyst Target Price has decreased from $2.5 to $1.Neutral
2020-05-27 06:35 ESTFinancialsCompany financials have been released.Neutral
2020-05-21 02:08 ESTFinancialsCompany financials have been released.Neutral
2020-05-15 21:33 ESTFinancialsCompany financials have been released.Neutral
2020-05-14 07:44 ESTNewsUnum Therapeutics EPS beats by $0.13, beats on revenueN/A
2020-05-06 06:43 ESTFinancialsCompany financials have been released.Neutral
2020-05-01 06:05 ESTFinancialsCompany financials have been released.Neutral
2020-04-28 06:21 ESTAnalyst RatingThe Analyst Target Price has increased from $1.83 to $2.5.Buy
2020-04-12 19:37 ESTNewsUnum Therapeutics down 18% on restructuringN/A
2020-04-12 19:37 ESTNewsEight Capital cuts view on Tilray after Q4 missN/A
2020-04-12 19:19 ESTNewsUnum Therapeutics inks $25M stock purchase agreement; shares up 6% premarketN/A
2020-04-12 19:13 ESTNewsUnum Therapeutics EPS beats by $0.35, beats on revenueN/A
2020-04-03 22:09 ESTFinancialsCompany financials have been released.Neutral
2020-03-31 05:41 ESTEarnings EstimateAn EPS average of -$0.71 is estimated for the 2021 year.Sell

About Cogent Biosciences, Inc (UMRX):

Unum Therapeutics Inc., a biopharmaceutical company, focuses on developing a pipeline of novel therapies to treat cancer patients. The company's novel proprietary technology, known as Bolt-On Chimeric Receptor (BOXR), is designed to improve the functionality of engineered T cells by discovering and incorporating a ?bolt-on' transgene into a patients' engineered T cells to overcome resistance of the solid tumor microenvironment to T cell attack. Its advanced program, PLX9486, is a selective KIT D816V inhibitor that is being developed to treat patients with systemic mastocytosis and gastrointestinal stromal tumors. The company was founded in 2014 and is headquartered in Cambridge, Massachusetts.

UMRX Quotes by TradingView

See Advanced Chart

General

  • Name Cogent Biosciences, Inc
  • Symbol UMRX
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Fiscal Year EndDecember
  • IPO Date2018-03-29
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.unumrx.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 3.49
  • Price/Book (Most Recent Quarter) 6.51
  • Enterprise Value Revenue 5.44
  • Enterprise Value EBITDA 0.4
View More

Financials

  • Most Recent Quarter 2020-09-30
  • Next Quarter EPS Estimate -$0.04
  • Return on Assets -26%
  • Revenue 26.48 million
  • Earnings Per Share -$1.36
  • Revenue Per Share $0.87
  • Gross Profit -21210000
  • Quarterly Earnings Growth -83.2%
View More

Highlights

  • Market Capitalization 73.23 million
  • EBITDA -40619000
  • Analyst Target Price $5
  • Book Value Per Share $0.50
View More

Share Statistics

  • Shares Outstanding 42.47 million
  • Shares Float 14.97 million
  • % Held by Insiders 3540%
  • % Held by Institutions 31.04%
  • Shares Short 601505
  • Shares Short Prior Month 988432
  • Short Ratio 0.85
  • Short % of Float 2%
  • Short % of Shares Outstanding 1%
View More

Technicals

  • Beta 1.31
  • 52 Week High $13.9
  • 52 Week Low $0.3
  • 50 Day Moving Average 11.65
  • 200 Day Moving Average 6.15
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
View More

Cogent Biosciences, Inc (UMRX) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Cogent Biosciences, Inc (UMRX) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-09-302020-11-09$312000-$5.07-$0.56-805.36%
2020-06-302020-08-11$528000-$0.96-$0.84-14.29%
2020-03-312020-05-11$7.03 million-$0.80-$1.2334.96%
2019-12-312020-03-26$15.29 million$0.28-$1.14124.56%
2019-09-302019-11-12$1.02 million-$1.56-$1.30-20%
2019-06-302019-08-12$3.14 million-$1.36-$1.6015%
2019-03-312019-05-13$3.05 million-$1.56-$1.33-17.29%
2018-12-312019-03-28$3.81 million-$1.16-$1.4117.73%
2018-09-302018-11-12$2.04 million-$1.36-$0.35-288.57%
2018-06-302018-08-13$1.67 million-$0.31-$0.348.82%
2018-03-312018-05-14$2.22 million-$0.66-$0.36-83.33%

Cogent Biosciences, Inc (UMRX) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Cogent Biosciences, Inc (UMRX) Chart:

UMRX chart by TradingView

Cogent Biosciences, Inc (UMRX) News:

Below you will find a list of latest news for Cogent Biosciences, Inc (UMRX) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Cogent Biosciences, Inc (UMRX) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Cogent Biosciences, Inc (UMRX) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919120035929/0001209191-20-035929-index.htm
2019-04-09UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1622229/000000000019006832/0000000000-19-006832-index.htm
2019-02-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1622229/000021545719006858/0000215457-19-006858-index.htm
2019-03-08SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1622229/000021545719007615/0000215457-19-007615-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1622229/000031506619001385/0000315066-19-001385-index.htm
2020-07-10SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1622229/000089706920000304/0000897069-20-000304-index.htm
2018-12-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000089924318031952/0000899243-18-031952-index.htm
2020-07-16SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1622229/000092189520001995/0000921895-20-001995-index.htm
2020-09-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1622229/000093583620000495/0000935836-20-000495-index.htm
2019-02-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1622229/000110465919006464/0001104659-19-006464-index.htm
2020-02-04SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1622229/000110465920010532/0001104659-20-010532-index.htm
2020-07-16SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1622229/000110465920084074/0001104659-20-084074-index.htm
2020-07-20SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1622229/000110465920084846/0001104659-20-084846-index.htm
2020-08-19SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1622229/000110465920096605/0001104659-20-096605-index.htm
2018-11-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1622229/000119312518324954/0001193125-18-324954-index.htm
2018-11-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1622229/000119312518324974/0001193125-18-324974-index.htm
2018-12-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1622229/000119312518340402/0001193125-18-340402-index.htm
2019-01-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1622229/000119312519001065/0001193125-19-001065-index.htm
2019-01-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1622229/000119312519003197/0001193125-19-003197-index.htm
2019-01-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1622229/000119312519014155/0001193125-19-014155-index.htm
2019-02-11SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1622229/000119312519033119/0001193125-19-033119-index.htm
2019-02-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1622229/000119312519038122/0001193125-19-038122-index.htm
2019-03-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1622229/000119312519066964/0001193125-19-066964-index.htm
2019-03-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1622229/000119312519089265/0001193125-19-089265-index.htm
2019-03-2810-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1622229/000119312519089299/0001193125-19-089299-index.htm
2019-03-28S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1622229/000119312519089341/0001193125-19-089341-index.htm
2019-04-02S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1622229/000119312519094845/0001193125-19-094845-index.htm
2019-04-29CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1622229/000119312519125106/0001193125-19-125106-index.htm
2019-04-30DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1622229/000119312519129799/0001193125-19-129799-index.htm
2019-04-30DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1622229/000119312519129813/0001193125-19-129813-index.htm
2019-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1622229/000119312519144767/0001193125-19-144767-index.htm
2019-05-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1622229/000119312519144768/0001193125-19-144768-index.htm
2019-06-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1622229/000119312519172646/0001193125-19-172646-index.htm
2019-06-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1622229/000119312519175720/0001193125-19-175720-index.htm
2019-06-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1622229/000119312519181239/0001193125-19-181239-index.htm
2019-07-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1622229/000119312519188282/0001193125-19-188282-index.htm
2019-07-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1622229/000119312519202590/0001193125-19-202590-index.htm
2019-07-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1622229/000119312519204735/0001193125-19-204735-index.htm
2019-08-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1622229/000119312519213092/0001193125-19-213092-index.htm
2019-08-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1622229/000119312519219015/0001193125-19-219015-index.htm
2019-11-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1622229/000119312519283356/0001193125-19-283356-index.htm
2019-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1622229/000119312519284527/0001193125-19-284527-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1622229/000119312519290014/0001193125-19-290014-index.htm
2019-12-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1622229/000119312519308661/0001193125-19-308661-index.htm
2020-01-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1622229/000119312520002212/0001193125-20-002212-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1622229/000119312520005920/0001193125-20-005920-index.htm
2020-01-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1622229/000119312520010115/0001193125-20-010115-index.htm
2020-01-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1622229/000119312520017633/0001193125-20-017633-index.htm
2020-02-07PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1622229/000119312520028331/0001193125-20-028331-index.htm
2020-02-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1622229/000119312520029096/0001193125-20-029096-index.htm
2020-02-18DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1622229/000119312520040685/0001193125-20-040685-index.htm
2020-03-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1622229/000119312520058074/0001193125-20-058074-index.htm
2020-03-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1622229/000119312520067221/0001193125-20-067221-index.htm
2020-03-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1622229/000119312520068831/0001193125-20-068831-index.htm
2020-03-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1622229/000119312520073772/0001193125-20-073772-index.htm
2020-03-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1622229/000119312520079968/0001193125-20-079968-index.htm
2020-03-20424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1622229/000119312520080016/0001193125-20-080016-index.htm
2020-03-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1622229/000119312520086037/0001193125-20-086037-index.htm
2020-03-26S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1622229/000119312520086958/0001193125-20-086958-index.htm
2020-04-08SC TO-ITender offer statement by Issuerhttps://www.sec.gov/Archives/edgar/data/1622229/000119312520101492/0001193125-20-101492-index.htm
2020-04-17PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1622229/000119312520110667/0001193125-20-110667-index.htm
2020-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1622229/000119312520126085/0001193125-20-126085-index.htm
2020-05-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1622229/000119312520139149/0001193125-20-139149-index.htm
2020-05-11SC TO-I/ATender offer statement by Issuerhttps://www.sec.gov/Archives/edgar/data/1622229/000119312520139243/0001193125-20-139243-index.htm
2020-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1622229/000119312520144042/0001193125-20-144042-index.htm
2020-06-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1622229/000119312520165765/0001193125-20-165765-index.htm
2020-07-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1622229/000119312520187492/0001193125-20-187492-index.htm
2020-07-30PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1622229/000119312520203416/0001193125-20-203416-index.htm
2020-08-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1622229/000119312520214974/0001193125-20-214974-index.htm
2020-08-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1622229/000119312520216445/0001193125-20-216445-index.htm
2020-08-19PRER14APreliminary Proxy Soliciting materialshttps://www.sec.gov/Archives/edgar/data/1622229/000119312520224245/0001193125-20-224245-index.htm
2020-09-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1622229/000119312520239042/0001193125-20-239042-index.htm
2020-09-22PRER14APreliminary Proxy Soliciting materialshttps://www.sec.gov/Archives/edgar/data/1622229/000119312520251265/0001193125-20-251265-index.htm
2020-09-22S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1622229/000119312520251424/0001193125-20-251424-index.htm
2020-10-02PRER14APreliminary Proxy Soliciting materialshttps://www.sec.gov/Archives/edgar/data/1622229/000119312520262526/0001193125-20-262526-index.htm
2020-10-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1622229/000119312520263412/0001193125-20-263412-index.htm
2020-10-0610-Q/AQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1622229/000119312520264799/0001193125-20-264799-index.htm
2020-10-06PRER14APreliminary Proxy Soliciting materialshttps://www.sec.gov/Archives/edgar/data/1622229/000119312520264858/0001193125-20-264858-index.htm
2020-10-09DEFM14ADefinitive proxy statement relating to merger or acquisitionhttps://www.sec.gov/Archives/edgar/data/1622229/000119312520267267/0001193125-20-267267-index.htm
2020-10-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1622229/000119312520275468/0001193125-20-275468-index.htm
2020-10-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1622229/000119312520276049/0001193125-20-276049-index.htm
2020-11-05S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1622229/000119312520286975/0001193125-20-286975-index.htm
2018-10-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919118053976/0001209191-18-053976-index.htm
2018-10-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919118056421/0001209191-18-056421-index.htm
2018-11-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919118059969/0001209191-18-059969-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919119002037/0001209191-19-002037-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919119002040/0001209191-19-002040-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919119002042/0001209191-19-002042-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919119002045/0001209191-19-002045-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919119002049/0001209191-19-002049-index.htm
2019-02-113Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919119009001/0001209191-19-009001-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919119013558/0001209191-19-013558-index.htm
2019-03-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919119021324/0001209191-19-021324-index.htm
2019-04-034/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919119023074/0001209191-19-023074-index.htm
2019-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919119023093/0001209191-19-023093-index.htm
2019-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919119023119/0001209191-19-023119-index.htm
2019-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919119023125/0001209191-19-023125-index.htm
2019-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919119023130/0001209191-19-023130-index.htm
2019-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919119023141/0001209191-19-023141-index.htm
2019-04-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919119024361/0001209191-19-024361-index.htm
2019-04-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919119024366/0001209191-19-024366-index.htm
2019-04-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919119024371/0001209191-19-024371-index.htm
2019-04-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919119024375/0001209191-19-024375-index.htm
2019-04-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919119024380/0001209191-19-024380-index.htm
2019-04-234/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919119025600/0001209191-19-025600-index.htm
2019-04-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919119026221/0001209191-19-026221-index.htm
2019-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919119037689/0001209191-19-037689-index.htm
2019-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919119037693/0001209191-19-037693-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919119038214/0001209191-19-038214-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919119038217/0001209191-19-038217-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919119038220/0001209191-19-038220-index.htm
2019-06-253Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919119038950/0001209191-19-038950-index.htm
2019-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919119038965/0001209191-19-038965-index.htm
2019-07-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919119041035/0001209191-19-041035-index.htm
2019-07-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919119041040/0001209191-19-041040-index.htm
2019-07-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919119041043/0001209191-19-041043-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919119042444/0001209191-19-042444-index.htm
2019-07-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919119042875/0001209191-19-042875-index.htm
2019-07-293Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919119043468/0001209191-19-043468-index.htm
2019-07-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919119043470/0001209191-19-043470-index.htm
2019-07-293Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919119043471/0001209191-19-043471-index.htm
2019-07-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919119043472/0001209191-19-043472-index.htm
2019-10-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919119052238/0001209191-19-052238-index.htm
2019-10-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919119052255/0001209191-19-052255-index.htm
2019-10-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919119052261/0001209191-19-052261-index.htm
2019-10-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919119052270/0001209191-19-052270-index.htm
2019-11-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919119057693/0001209191-19-057693-index.htm
2019-11-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919119057694/0001209191-19-057694-index.htm
2020-01-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919120001885/0001209191-20-001885-index.htm
2020-01-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919120001886/0001209191-20-001886-index.htm
2020-01-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919120001888/0001209191-20-001888-index.htm
2020-01-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919120001889/0001209191-20-001889-index.htm
2020-02-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919120009285/0001209191-20-009285-index.htm
2020-02-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919120009287/0001209191-20-009287-index.htm
2020-02-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919120009289/0001209191-20-009289-index.htm
2020-02-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919120009293/0001209191-20-009293-index.htm
2020-02-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919120009297/0001209191-20-009297-index.htm
2020-04-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919120023943/0001209191-20-023943-index.htm
2020-04-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919120023944/0001209191-20-023944-index.htm
2020-04-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919120023945/0001209191-20-023945-index.htm
2020-04-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919120023946/0001209191-20-023946-index.htm
2020-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919120035923/0001209191-20-035923-index.htm
2020-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919120035925/0001209191-20-035925-index.htm
2020-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919120035926/0001209191-20-035926-index.htm
2020-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919120035928/0001209191-20-035928-index.htm
2020-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919120035929/0001209191-20-035929-index.htm
2020-07-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919120041003/0001209191-20-041003-index.htm
2020-07-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919120041016/0001209191-20-041016-index.htm
2020-07-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919120041017/0001209191-20-041017-index.htm
2020-07-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919120041045/0001209191-20-041045-index.htm
2020-07-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919120041824/0001209191-20-041824-index.htm
2020-08-183Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919120047243/0001209191-20-047243-index.htm
2020-08-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919120047288/0001209191-20-047288-index.htm
2020-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919120053276/0001209191-20-053276-index.htm
2020-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919120053277/0001209191-20-053277-index.htm
2020-10-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919120054312/0001209191-20-054312-index.htm
2020-10-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919120054904/0001209191-20-054904-index.htm
2020-10-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919120055908/0001209191-20-055908-index.htm
2020-10-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000120919120055909/0001209191-20-055909-index.htm
2019-08-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1622229/000156459019031485/0001564590-19-031485-index.htm
2019-11-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1622229/000156459019042995/0001564590-19-042995-index.htm
2020-03-2610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1622229/000156459020013188/0001564590-20-013188-index.htm
2020-05-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1622229/000156459020024313/0001564590-20-024313-index.htm
2020-08-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1622229/000156459020039357/0001564590-20-039357-index.htm
2020-07-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000156761920013082/0001567619-20-013082-index.htm
2020-07-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000156761920013084/0001567619-20-013084-index.htm
2020-07-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000156761920013202/0001567619-20-013202-index.htm
2020-07-153Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000156761920013313/0001567619-20-013313-index.htm
2020-07-153Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000156761920013315/0001567619-20-013315-index.htm
2020-08-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000156761920016159/0001567619-20-016159-index.htm
2020-08-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000156761920016161/0001567619-20-016161-index.htm
2020-07-21DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000162222920000001/0001622229-20-000001-index.htm
2020-07-21DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1622229/000162222920000002/0001622229-20-000002-index.htm
2019-05-01EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1622229/999999999519000978/9999999995-19-000978-index.htm
2020-10-15EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1622229/999999999520002858/9999999995-20-002858-index.htm

Cogent Biosciences, Inc (UMRX) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Cogent Biosciences, Inc (UMRX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 3540%
Institutional Ownership: 3104%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2018-10-25Seth EttenbergChief Scientific OfficerSell11,485.008.4697,201.000.00https://www.sec.gov/Archives/edgar/data/1622229/000120919118056421/0001209191-18-056421-index.htm
2018-11-26Seth EttenbergChief Scientific OfficerSell11,485.007.0080,444.390.00https://www.sec.gov/Archives/edgar/data/1622229/000120919118059969/0001209191-18-059969-index.htm
2018-12-26Seth EttenbergChief Scientific OfficerSell11,485.004.0546,486.690.00https://www.sec.gov/Archives/edgar/data/1622229/000089924318031952/0000899243-18-031952-index.htm
2019-02-25Seth EttenbergChief Scientific OfficerSell11,485.004.2548,852.600.00https://www.sec.gov/Archives/edgar/data/1622229/000120919119013558/0001209191-19-013558-index.htm
2019-03-25Seth EttenbergChief Scientific OfficerSell11,485.004.1247,334.280.00https://www.sec.gov/Archives/edgar/data/1622229/000120919119021324/0001209191-19-021324-index.htm
2020-07-06John L. GreenChief Financial OfficerBuy109,459.00109,459.00https://www.sec.gov/Archives/edgar/data/1622229/000120919120041824/0001209191-20-041824-index.htm
2018-10-25Seth EttenbergChief Scientific OfficerBuy11,485.000.182,067.3011,485.00https://www.sec.gov/Archives/edgar/data/1622229/000120919118056421/0001209191-18-056421-index.htm
2018-11-26Seth EttenbergChief Scientific OfficerBuy11,485.000.182,067.3011,485.00https://www.sec.gov/Archives/edgar/data/1622229/000120919118059969/0001209191-18-059969-index.htm
2018-12-26Seth EttenbergChief Scientific OfficerBuy11,485.000.182,067.3011,485.00https://www.sec.gov/Archives/edgar/data/1622229/000089924318031952/0000899243-18-031952-index.htm
2019-02-25Seth EttenbergChief Scientific OfficerBuy11,485.000.182,067.3011,485.00https://www.sec.gov/Archives/edgar/data/1622229/000120919119013558/0001209191-19-013558-index.htm
2019-03-25Seth EttenbergChief Scientific OfficerBuy11,485.000.182,067.3011,485.00https://www.sec.gov/Archives/edgar/data/1622229/000120919119021324/0001209191-19-021324-index.htm
2020-08-14Venrock Healthcare Capital Partners III, L.P.10% Share HolderBuy100,000.002.30230,000.004,004,273.00https://www.sec.gov/Archives/edgar/data/1622229/000120919120047288/0001209191-20-047288-index.htm
2020-08-17Venrock Healthcare Capital Partners III, L.P.10% Share HolderBuy250,000.002.57642,500.004,254,273.00https://www.sec.gov/Archives/edgar/data/1622229/000120919120047288/0001209191-20-047288-index.htm
2020-08-18Venrock Healthcare Capital Partners III, L.P.10% Share HolderBuy101,000.002.62264,620.004,355,273.00https://www.sec.gov/Archives/edgar/data/1622229/000120919120047288/0001209191-20-047288-index.htm